Candidate gene approaches have been applied based on genes that show transcriptional dysregulation in HD [111], revealing increased 5mC levels and reduced 5hmC in the 5′UTR region of ADORA2A in the putamen of HD patients with respect to controls [112]. This evidence concerns the gene ADORA2A and Huntington disease.